According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation
Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates
aHR, adjusted hazard ratio
At baseline and 24 weeks following the intervention, we measured the following clinical and laboratory parameters before breakfast on day 1 of CGM [17]: BW, low-density lipoprotein cholesterol (LDL-C) levels, high-density lipoprotein cholesterol (HDL-C) levels, triglyceride (TG) levels, eGFR, blood pressure, fasting plasma glucose (FPG) levels, and HbA1c levels
hCG, gonadorelin, and kisspeptin are usually discussed because they relate to endogenous signaling rather than direct testosterone replacement
Take-Home Message: Is Wegovy the Right Treatment for Your Weight Goals